Florida Cancer Innovation Fund
This funding opportunity supports healthcare entities in Florida to develop innovative cancer research and treatment projects that improve patient care and access to services, particularly in underserved communities.
The Florida Cancer Innovation Fund (FCIF), created by the 2024 Florida Legislature and operated within the Casey DeSantis Cancer Research Program, aims to drive transformative progress in cancer research and treatment across Florida. Managed by the Florida Department of Health and advised by the Florida Cancer Connect Collaborative, the program promotes short-term, high-impact projects that enhance access to innovative cancer care and accelerate clinical translation, commercialization, and policy adoption. With approximately $60 million allocated for fiscal year 2025β2026, the fund supports seven distinct grant categories, including Rapid Translation, Clinical Trials, Consortium research, Nutrition-Based Cancer Prevention, and Generic Drug Repurposing. Each funded project must be completed within a strict 12-month timeline and demonstrate immediate and measurable impact on patient care, cancer prevention, healthcare delivery, or economic outcomes. All activities must be conducted in Florida, with rare exceptions for essential out-of-state services under 10% of the budget. Eligible applicants include licensed hospitals, clinics, and other healthcare entities meeting at least one of ten statutory eligibility criteria, such as serving rural/underserved communities, offering chemotherapy or radiation, providing low-cost screenings, or advancing biomedical cancer research. All applicants must designate a single Principal Investigator who meets residency and employment requirements. Collaboration across institutions is encouraged. Applications are accepted on a rolling basis, with three closing dates during the fiscal year: October 27, November 25, 2025, and January 9, 2026. Each PI may submit only one application per fiscal year, per grant category. Submitted projects are reviewed by the Cancer Connect Collaborative, and successful applicants must comply with detailed post-award reporting and open-access data sharing obligations. Applications must include a scientific abstract, specific aims, work plan, budget, evaluation metrics, and regulatory approvals. Emphasis is placed on projects with immediate scalability, impact in underserved areas, innovative methodologies, and potential for extramural funding. The maximum grant award is $2 million, and all spending must adhere to state-specific disallowed cost guidelines.
Award Range
Not specified - $2,000,000
Total Program Funding
$60,000,000
Number of Awards
Not specified
Matching Requirement
No
Additional Details
Max $2M per award; project must complete within 12 months; all work must be conducted in Florida; seven grant categories; dedicated categories include nutrition and generic drug repurposing; direct costs only; see disallowed cost list
Eligible Applicants
Additional Requirements
Eligible applicants must be Florida-based licensed healthcare providers, research facilities, or training programs that meet one of ten eligibility categories including operating hospitals, clinics, radiation/chemotherapy centers, or those conducting cancer research or training. Work must be performed in Florida, and all regulatory approvals must be in place before contract execution.
Geographic Eligibility
All
Prepare all regulatory approvals in advance; only one application per grant category allowed; focus on measurable 12-month outcomes; highlight rural, nutrition, or accessibility impacts
Next Deadline
October 1, 2025
Pre-application webinar and Q&A deadline
Application Opens
September 29, 2025
Application Closes
January 9, 2026
Subscribe to view contact details
Subscribe to access grant documents